| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE: 002864)
002864 Technical Analysis
4
| As on 28th Nov 2025 002864 STOCK Price closed @ 34.64 and we RECOMMEND Buy for LONG-TERM with Stoploss of 28.94 & Strong Buy for SHORT-TERM with Stoploss of 28.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002864STOCK Price
| Open | 35.50 | Change | Price | % |
| High | 35.50 | 1 Day | -1.72 | -4.73 |
| Low | 34.32 | 1 Week | 0.29 | 0.84 |
| Close | 34.64 | 1 Month | 4.73 | 15.81 |
| Volume | 10278039 | 1 Year | 5.82 | 20.19 |
| 52 Week High 39.20 | 52 Week Low 25.43 | ||||
SHE China Most Active Stocks
| 300058 | 10.73 | 1.32% |
| 000592 | 10.73 | 10.05% |
| 000078 | 3.40 | 10.03% |
| 000547 | 13.51 | 10.02% |
| 000620 | 3.26 | 4.49% |
| 000627 | 1.58 | 1.28% |
| 000981 | 3.32 | 2.15% |
| 000002 | 5.38 | -1.65% |
| 300189 | 6.00 | 8.89% |
| 300123 | 7.49 | 13.48% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 002864 Daily Charts |
002864 Intraday Charts |
Whats New @ Bazaartrend |
002864 Free Analysis |
|
|
002864 Important Levels Intraday
| RESISTANCE | 36.91 |
| RESISTANCE | 36.18 |
| RESISTANCE | 35.73 |
| RESISTANCE | 35.28 |
| SUPPORT | 34.00 |
| SUPPORT | 33.55 |
| SUPPORT | 33.10 |
| SUPPORT | 32.37 |
002864 Forecast November 2025
| 4th UP Forecast | 41.92 |
| 3rd UP Forecast | 39.59 |
| 2nd UP Forecast | 38.14 |
| 1st UP Forecast | 36.7 |
| 1st DOWN Forecast | 32.58 |
| 2nd DOWN Forecast | 31.14 |
| 3rd DOWN Forecast | 29.69 |
| 4th DOWN Forecast | 27.36 |
002864 Weekly Forecast
| 4th UP Forecast | 46.24 |
| 3rd UP Forecast | 42.52 |
| 2nd UP Forecast | 40.22 |
| 1st UP Forecast | 37.92 |
| 1st DOWN Forecast | 31.36 |
| 2nd DOWN Forecast | 29.06 |
| 3rd DOWN Forecast | 26.76 |
| 4th DOWN Forecast | 23.04 |
002864 Forecast2025
| 4th UP Forecast | 70.93 |
| 3rd UP Forecast | 59.29 |
| 2nd UP Forecast | 52.1 |
| 1st UP Forecast | 44.9 |
| 1st DOWN Forecast | 24.38 |
| 2nd DOWN Forecast | 17.18 |
| 3rd DOWN Forecast | 9.99 |
| 4th DOWN Forecast | -1.65 |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd ( SHE China Symbol : 002864 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002864 Other Details
| Segment | EQ | |
| Market Capital | 1911073408.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > echo $website ; ?> | |
002864 Address
![]() |
||
002864 Latest News
002864 Business Profile
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells drugs and GAP cultivation of medicinal materials in China. It offers orthopedic, cardio-cerebrovascular, digestive, supplement category, respiratory, Chinese anti-inflammatory, pediatric, gynecology, hepatobiliary, and specialty drugs. The company was founded in 1992 and is headquartered in Xi'an, China. Address: Modern Textile Industrial Park, Xi'an, China, 710025
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

